Meeting the Demands of a Changing Clinical Research Landscape

Leveraging an FSP model to support non-footprint countries provides greater resource flexibility and access to specific expertise not readily available in-house. This model is also growing in popularity, as the FSP market has grown substantially in recent years and is projected to continue at a compound annual growth rate of more than 7% from 2023 to 2027.

A 2023 survey of biopharma and biotech leaders conducted by PPD® also revealed an increase in FSP outsourcing over the past two years, with 41% of respondents reporting increased use of FSP models

Please fill the below form to download

Download